At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.33B, above the global median of $1.14B
- PositionDebt-to-equity is 0.01×, lower than 95% of its Medical Instruments & Supplies peers (median 0.18×)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.57%Below 5Y avg (1.03%)
Annual Rate
CNY 0.07Paid annual
Payout Ratio
42.4%Sustainable
Last Ex-Dividend
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.85BCNY1.33B · vs all stocks (USD)
Trailing P/E
34.24xvs Medical Instruments & Supplies peers
Revenue (TTM)
5.15BCNY771.05M · vs all stocks (USD)
Profit Margin
5.14%vs Medical Instruments & Supplies peers
Beta
0.4240xvs all stocks
52-Week Change
-26.43%vs all stocks
Market Capitalization
8.85BCNY1.33B · vs all stocks (USD)
Enterprise Value
5.42BCNY811.62M · vs all stocks (USD)
Trailing P/E
34.24xvs Medical Instruments & Supplies peers
Forward P/E
17.91xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.73xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.11xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.05xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
10.87xvs Medical Instruments & Supplies peers
Gross Margin
33.40%vs Medical Instruments & Supplies peers
Profit Margin
5.14%vs Medical Instruments & Supplies peers
Operating Margin
6.39%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.51%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.73%vs Medical Instruments & Supplies peers
Revenue (TTM)
5.15BCNY771.05M · vs all stocks (USD)
Revenue per Share (TTM)
6.68CNYUpdated Nov 20, 2026Quarterly Revenue Growth
-15.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.47BCNY220.69M · vs all stocks (USD)
EBITDA (TTM)
538.25MCNY80.66M · vs all stocks (USD)
Net Income (TTM)
264.68MCNY39.66M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
752.08MCNY112.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
563.16MCNY84.40M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0660CNYUpdated Nov 20, 2026Trailing Annual Dividend Yield
0.57%vs all stocks
5-Year Average Dividend Yield
1.03%vs all stocks
Payout Ratio
42.38%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
238.45MCNYFY2025 · Dec 31, 2025Revenue
5.23BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.70BCNYFY2025 · Dec 31, 2025Gross Profit
1.54BCNYFY2025 · Dec 31, 2025Operating Income
325.21MCNY48.74M · vs all stocks (USD)
Pre-tax Income
264.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.28MCNYFY2025 · Dec 31, 2025Net Income
211.89MCNYFY2025 · Dec 31, 2025EBIT
265.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
538.25MCNYFY2025 · Dec 31, 2025Research & Development
337.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
361.04MCNYFY2025 · Dec 31, 2025Other Operating Expenses
45.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
37.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
211.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-11.51MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
220.08MCNYFY2025 · Dec 31, 2025Free Cash Flow
-49.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
211.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
26.86MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
58.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-77.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-269.14MCNYFY2025 · Dec 31, 2025Net Acquisitions
42.02MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.89BCNYFY2025 · Dec 31, 2025Sale of Investments
2.98BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-133.53MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
76.70MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-82.02MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.81MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-21.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
765.83MSharesUpdated Nov 20, 2026Float Shares
364.29MSharesUpdated Nov 20, 2026% Held by Insiders
53.03%vs all stocks
% Held by Institutions
11.53%vs all stocks
Total Cash (MRQ)
4.17BCNY624.28M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.47CNYUpdated Nov 20, 2026Total Debt (MRQ)
113.98MCNY17.08M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0138xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.91xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
10.53CNYUpdated Nov 20, 2026Total Assets
13.51BCNY2.02B · vs all stocks (USD)
Total Current Assets
10.17BCNYFY2025 · Dec 31, 2025Total Liabilities
5.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.34BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
210.37MCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.13BCNYFY2025 · Dec 31, 2025Cash
3.05BCNYFY2025 · Dec 31, 2025Cash Equivalents
69.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.12BCNYFY2025 · Dec 31, 2025Other Short-term Investments
714.71MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.59BCNYFY2025 · Dec 31, 2025Inventory
3.20BCNYFY2025 · Dec 31, 2025Accounts Payable
1.08BCNYFY2025 · Dec 31, 2025Short-term Debt
15.98MCNYFY2025 · Dec 31, 2025Other Current Liabilities
180.68MCNYFY2025 · Dec 31, 2025Long-term Debt
72.19MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
765.83MCNYFY2025 · Dec 31, 2025Retained Earnings
3.17BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.17BCNY1.22B · vs all stocks (USD)
Treasury Stock
63.94MCNYFY2025 · Dec 31, 202552-Week Low
10.42CNYUpdated Nov 20, 202652-Week High
20.37CNYUpdated Nov 20, 202652-Week Change
-26.43%vs all stocks
Beta
0.4240xvs all stocks
50-Day MA
14.53CNYUpdated Nov 20, 2026200-Day MA
13.83CNYUpdated Nov 20, 2026Avg 10-Day Volume
10.76MSharesUpdated Nov 20, 2026Avg 30-Day Volume
13.46MSharesUpdated Nov 20, 2026Diluted EPS (TTM)
0.3400CNYUpdated Nov 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0.01×, lower than 95% of its Medical Instruments & Supplies peers (median 0.18×)Notable
Debt-to-equity: 0.01Industry median: 0.18Industry P5: 0.01Peers compared: 35.00
Financial Health
Altman Z-Score 2.22: grey zoneSignificant
Altman Z-Score: 2.22
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.33B, above the global median of $1.14BNotable
Market cap (USD): 1,325,558,735.359Global Median: 1,137,180,293.291
Revenue is $771.05M, above the global median of $566.17MNotable
Revenue (USD): 771,045,419.715Global Median: 566,172,992
Levered free cash flow is $84.4M, above the global median of $18.58MNotable
Levered free cash flow (USD): 84,395,090.463Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Wankai New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Camelot Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changchun UP Optotech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Huapont Life Sciences Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Edadoc Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinofibers Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Datang Telecom Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Zaisheng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sidea Semiconductor Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CEAT Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule